All Stories

  1. Azygos Venous Pressure and Respiratory Modulation of CSF–Venous Pressure Gradients in SIH and IIH patients
  2. Drug‐associated central nervous system vasculitis and reversible cerebral vasoconstriction syndrome: A global disproportionality analysis of the WHO pharmacovigilance database (VigiBase)
  3. Brain Volume Changes After Targeted Closure of Spinal CSF Leak in Spontaneous Intracranial Hypotension
  4. Characterization of meningeal diverticula in patients with cerebrospinal fluid-venous fistulas
  5. Hypertension intracrânienne idiopathique, la malnommée – un concept évolutif
  6. Hypotension intracrânienne spontanée
  7. Physiopathologie de la migraine
  8. Le traitement de la migraine chez l’adulte
  9. Endovascular treatment of a sacral cerebrospinal fluid–venous Fistula using transvenous embolization: A case report
  10. Navigating the epidural plexus: a venographic classification system to predict technical feasibility in cerebrospinal fluid-venous fistula embolization
  11. Regional Differences in Presentation, Cause, and Outcome of Reversible Cerebral Vasoconstriction Syndrome
  12. Validation of an 8-item self-administered questionnaire for assessing migraine-related sensory hypersensitivities (MHQ-8)
  13. The impact of CSF venous fistula embolization on patient’s quality of life, a longitudinal clinical-radiological exploration
  14. Early brain MRI changes following transvenous embolization of cerebrospinal fluid-venous fistulas in spontaneous intracranial hypotension
  15. Concordance between venous sinus pressure and intracranial pressure in patients investigated for idiopathic intracranial hypertension
  16. Prevalence, clinical presentation, and treatment-management of cerebral venous thrombosis associated with spontaneous intracranial hypotension: A combined case-series and systematic literature review approach
  17. Silent brain infarct in migraine: Systematic review and meta-analysis
  18. Safety and efficacy of transvenous embolization of cerebrospinal fluid-venous fistula in patients with spontaneous intracranial hypotension
  19. A technique to localize posteriorly located spinal dural leaks associated with spontaneous intracranial hypotension: Dorsal-decubitus dynamic CT myelography
  20. Pathogenic SCN2A variants are associated with familial and sporadic hemiplegic migraine
  21. Case report: Meningitis: a cause of reversible cerebral vasoconstriction syndrome?
  22. Reversible cerebral Vasoconstriction syndrome intERnational CollaborativE (REVERCE) network: Study protocol and rationale of a multicentre research collaboration
  23. Complications of reversible cerebral vasoconstriction syndrome in relation to age
  24. Genetics of migraine: where are we now?
  25. Outcomes among patients with primary angiitis of the CNS: A Nationwide United States analysis
  26. European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
  27. The teaching of headache medicine in France: A questionnaire‐based study
  28. Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data
  29. Diagnostic utility of T2*-weighted GRE in migraine with aura attack. The cortical veins sign
  30. Genetics of migraine
  31. Systematic Review and Meta-analysis of Acute Treatments for Episodic Migraine in Adults
  32. Hemiplegic Migraine Associated With PRRT2 Variations
  33. Outcomes Among Patients With Reversible Cerebral Vasoconstriction Syndrome: A Nationwide United States Analysis
  34. Genetics of migraine
  35. Revised guidelines of the French Headache Society for the diagnosis and management of migraine in adults. Part 1: Diagnosis and assessment
  36. Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: Pharmacological treatment
  37. Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 3: Non-pharmacological treatment
  38. Foreword
  39. Type of headache at onset and risk for complications in reversible cerebral vasoconstriction syndrome
  40. Diagnosis and management of migraine in ten steps
  41. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
  42. Burden and Attitude to Resistant and Refractory Migraine A Survey From the European Headache Federation With the Endorsement of the European Migraine & Headache Alliance
  43. Severe migraine and its control: A proposal for definitions and consequences for care
  44. Mechanical Thrombectomy in Nighttime Hours: Is There a Difference in 90-Day Clinical Outcome for Patients with Ischemic Stroke?
  45. Oral steroids for episodic cluster headache
  46. Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome
  47. Acute retinal arterial ischaemia: silent brain infarcts prevalence and short‐term recurrence
  48. European headache federation consensus on the definition of resistant and refractory migraine
  49. Long-Term Outcomes After Reversible Cerebral Vasoconstriction Syndrome
  50. Early and late infratentorial haemorrhages sharing a common mechanism
  51. Concomitant reversible cerebral vasoconstriction syndrome and transient global amnesia
  52. Reversible cerebral vasoconstriction syndrome
  53. A Clinico-Radiological Study of Cerebral Amyloid Angiopathy-Related Inflammation
  54. Reversible giant arachnoid granulations
  55. Primary angiitis of the CNS and reversible cerebral vasoconstriction syndrome
  56. Recommandations pour le diagnostic et la prise en charge de la névralgie trigéminale classique
  57. Genetics of migraine
  58. Migraine with brainstem aura: Why not a cortical origin?
  59. French guidelines for diagnosis and treatment of classical trigeminal neuralgia (French Headache Society and French Neurosurgical Society)
  60. Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache
  61. The Link Between Migraine, Reversible Cerebral Vasoconstriction Syndrome and Cervical Artery Dissection
  62. The Typical Thunderclap Headache of Reversible Cerebral Vasoconstriction Syndrome and its Various Triggers
  63. Occipital neuralgia heralding occipital condyle syndrome revealing vesical leiomyosarcoma skull base metastasis
  64. Recurrence of Migraine With Aura After a 24-year Free Period Following rTMS Treatment for Fibromyalgia Pain
  65. Headache arising from idiopathic changes in CSF pressure
  66. Are migraineurs naturally born “well-hearted”?
  67. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection
  68. RCVS and CVT
  69. Comment: Reversible cerebral vasoconstriction syndrome can hit twice
  70. La migraine joue-t-elle sur les vaisseaux ?
  71. Génétique des céphalées1
  72. Ischaemic Strokes with Reversible Vasoconstriction and without Thunderclap Headache: A Variant of the Reversible Cerebral Vasoconstriction Syndrome?
  73. Sindrome di vasocostrizione cerebrale reversibile
  74. Recommandations pour le diagnostic et le traitement de l’algie vasculaire de la face
  75. La vasodilatation a-t-elle un rôle dans la migraine ? Commentaires
  76. Le syndrome post-ponction lombaire. Revue de la littérature et expérience des urgences céphalées
  77. Reversible cerebral vasoconstriction syndrome and treatment with monoamine oxidase inhibitor
  78. Carotid paraganglioma mimicking a cluster headache
  79. Familial hemiplegic migraine: A model for the genetic studies of migraine
  80. Phénotypes de l’aura migraineuse
  81. Céphalée du naufrage, une entité absente de la nouvelle classification ICHD-3
  82. Reversible Cerebral Vasoconstriction Syndrome
  83. Subarachnoid and intra-cerebral hemorrhage in young adults: Rare and underdiagnosed
  84. Reversible cerebral vasoconstriction syndrome
  85. Physiopathologie et génétique de la migraine
  86. Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients
  87. The International Classification of Headache Disorders, 3rd edition (beta version)
  88. Génétique de la migraine
  89. L37. Reversible cerebral vasoconstriction syndrome: Distinction from CNS vasculitis
  90. Nouvelle approche pharmacologique des traitements de fond
  91. Occipital Injections for Trigemino-Autonomic Cephalalgias: Evidence and Uncertainties
  92. Migraine et céphalée de tension : ce que doit connaître le rhumatologue
  93. CERVCO, Centre de référence des maladies vasculaires rares du cerveau et de l’oeil
  94. Thunderclap headache
  95. Migraine, Genetics
  96. Use of cannabis among 139 cluster headache sufferers
  97. Reversible cerebral vasoconstriction syndrome
  98. Emotional Status, Perceived Control of Pain, and Pain Coping Strategies in Episodic and Chronic Cluster Headache
  99. Anne Ducros
  100. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial
  101. Use of Antimigraine Treatments by General Practitioners
  102. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management
  103. Headache Attributed to Giant Cell (Temporal) Arteritis
  104. Reversible Cerebral Vasoconstriction Syndromes
  105. Acute Headache in the Emergency Department
  106. Hemorrhagic Manifestations of Reversible Cerebral Vasoconstriction Syndrome
  107. De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine
  108. Génétique de la migraine
  109. Reversible cerebral vasoconstriction syndrome in two patients with a carotid glomus tumour
  110. Le syndrome de vasoconstriction cérébrale réversible
  111. Syndrome de vasoconstriction cérébrale réversible
  112. Acute headache in the emergency department
  113. Reversible cerebral vasoconstriction syndrome
  114. Génétique des céphalées
  115. Emergency Treatment of Migraine
  116. Postpartum Cervicocephalic Artery Dissection
  117. Migraine hémiplégique familiale et sporadique
  118. Cluster headache
  119. Aspects cliniques et radiologiques du syndrome de vasoconstriction cérébrale réversible. Une série prospective de 67 patients
  120. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients
  121. Most Cases Labeled as ???Retinal Migraine??? Are Not Migraine
  122. Hemiplegic Migraine: Clinical Features, Links with Basilar-type Migraine, Current and Future Treatment
  123. Late-onset eosinophilic chronic meningitis occurring 30 years after Taenia solium infestation in a white Caucasian woman
  124. Chronic Paroxysmal Hemicrania in a Patient with a Macroprolactinoma
  125. Physiopathologie et approche g??n??tique de la migraine
  126. Migraine
  127. Treating Depression in Children and Adolescents
  128. ATP1A2 mutations in 11 families with familial hemiplegic migraine
  129. A Negative D-Dimer Assay Does Not Rule Out Cerebral Venous Thrombosis: A Series of Seventy-Three Patients
  130. Céphalées en coup de tonnerre
  131. Démarche diagnostique et thérapeutique dans 40 cas d’hypotension intracrânienne spontanée
  132. Early epidural blood patch in spontaneous intracranial hypotension
  133. Migraine hémiplégique familiale
  134. Migraine ophtalmique ou migraine avec aura visuelle
  135. Familial Cluster Headache: A Series of 186 Index Patients
  136. The Genetics of Migraine
  137. Absence of linkage to 8q24 in a European family with familial adult myoclonic epilepsy (FAME)
  138. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis
  139. The Clinical Spectrum of Familial Hemiplegic Migraine Associated with Mutations in a Neuronal Calcium Channel
  140. Sporadic late onset paroxysmal cerebellar ataxia in four unrelated patients: a new disease?
  141. Missense CACNA1A Mutation Causing Episodic Ataxia Type 2
  142. Mutations de CACNA1A et migraine hémiplégique familiale.
  143. Genetics of familial hemiplegic migraine
  144. Cluster Headache
  145. CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy
  146. Decreased hemispheric water mobility in hemiplegic migraine related to mutation of CACNA1A gene
  147. Migraine and ataxias
  148. Recurrent Episodes of Coma: An Unusual Phenotype of Familial Hemiplegic Migraine with Linkage to Chromosome 1
  149. High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2
  150. Recurrence of the T666M Calcium Channel CACNA1A Gene Mutation in Familial Hemiplegic Migraine with Progressive Cerebellar Ataxia
  151. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity
  152. Notch3 Mutations in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), a Mendelian Condition Causing Stroke and Vascular Dementia
  153. HEREDITARY PAROXYSMAL ATAXIAS
  154. A Human Homolog of Bacterial Acetolactate Synthase Genes Maps within the CADASIL Critical Region
  155. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
  156. Monozygotic twins discordant for familial hemiplegic migraine
  157. A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p
  158. Headache in the Emergency Room
  159. Migraine, Genetics
  160. Emotional Status, Perceived Control of Pain, and Pain Coping Strategies in Episodic and Chronic Cluster Headache